Close
Written By: Jeffrey Atlas, PA-C, Health Content Writer
Medically Reviewed By: Dr. Gopal Grandhige, MD, FACS, Board-Certified Surgeon
Last Reviewed: June 5, 2026
MOTS-C can be stacked with several other peptides, and the pairings that hold up best are the ones built on completely different biological mechanisms.
The standout combination right now? MOTS-C with Retatrutide.
MOTS-C is a 16-amino-acid peptide that lives inside your mitochondria, where it activates AMPK and pushes cells to burn fat for fuel. Retatrutide is a newer triple-receptor agonist that hits GLP-1, GIP, and glucagon receptors at once, producing fat-loss results that beat anything that came before it.
These two compounds don’t compete for the same receptors. They don’t share metabolic shortcuts. They handle different problems. Retatrutide turns down hunger and signals your liver to release stored fat, while MOTS-C makes sure your cells can actually burn what gets released.
At Formation in Tampa, we’ve watched this pairing work for the right patient. Keep reading and I’ll explain who that actually is, where most people go wrong, and what we won’t recommend stacking under any circumstances.
MOTS-C stands for Mitochondrial Open Reading Frame of the 12S rRNA Type-C. The mouthful matters because most peptides come from nuclear DNA. MOTS-C is one of the few that gets coded directly inside your mitochondria, which is also where it does its work.
Your mitochondria are the energy factories inside every cell. They take what you eat and turn it into ATP, the fuel cells run on. When mitochondria slow down (from age, chronic stress, poor diet, or being sedentary), your whole metabolism slows with them. Energy drops. Fat sticks. Recovery drags.
MOTS-C activates AMPK, the master switch that tells cells to start burning fat instead of storing it. When AMPK fires, glucose uptake in muscle goes up, fat oxidation goes up, inflammation comes down, and cells get better at handling stress. Researchers at USC who first identified MOTS-C in 2015 called it an “exercise mimetic” because it triggers many of the same metabolic signals as a hard workout. Later work has built on that finding, including a 2023 peer-reviewed review on MOTS-C’s role in metabolic disorders.
Here’s the part most clinics gloss over: MOTS-C levels naturally drop by around 21% between age 30 and 80. That decline maps almost exactly to the slow metabolic decay people complain about in their 40s and 50s. The premise behind injecting MOTS-C is restoring what time has taken.
That doesn’t make it a miracle. It’s not. I’ve had patients walk into Formation expecting MOTS-C to do the work of diet and training, and they’re always disappointed. The peptide amplifies what you’re already doing. Skip the lifestyle work and you’ll get modest results at best.
The injectable form goes under the skin, usually in the abdomen or thigh. Half-life runs short, around one to two hours in circulation, which is why most protocols dose two or three times a week instead of once.
The honest answer: because no single peptide handles every problem.
Each one targets a narrow pathway. MOTS-C handles cellular energy. GLP-1 agonists handle appetite. Growth hormone peptides handle muscle and recovery. Repair peptides handle gut and tissue healing. Stack two that work on different systems and you cover more ground without piling on side effects from the same receptor getting hit twice.
That’s the theory. The practice is messier.
Most patients who come to Formation asking about stacks are repeating something they heard on a podcast or read in a forum, and the recommendation usually involves three or four compounds that all overlap. I’ve turned down more peptide stack requests than I’ve approved. When someone tells me they want MOTS-C, Retatrutide, Tirzepatide, BPC-157, and Tesamorelin all running together, I push back hard.
Here’s the contrarian take that gets pushback from the bro-science crowd: more is almost never better with peptides. Each additional compound adds variables that make it harder to figure out what’s working and what’s hurting. A clean two-peptide stack with separate mechanisms beats a five-peptide stack with overlapping mechanisms every time.
The other reason to stack is to cover weaknesses in a single-compound protocol. GLP-1 medications like Retatrutide and tirzepatide suppress appetite so hard that patients sometimes lose energy and muscle along with fat. Adding MOTS-C addresses both gaps.
What this article won’t cover: every theoretical stack combination floating around online. There are dozens of them, and most have no data behind them. I’m sticking to the ones we’ve actually used at Formation or seen in published research.
If you’ve spent any time on peptide forums in the last 12 months, you’ve seen this pairing come up over and over. There’s a reason.
Retatrutide is the first triple-agonist peptide to hit GLP-1, GIP, and glucagon receptors at the same time. The Phase 2 trial data was striking. Patients on the 12mg weekly dose lost an average of 24.2% of body weight over 48 weeks. For comparison, semaglutide tops out around 15% and tirzepatide around 21%. As of mid-2026, Retatrutide is still in Phase 3 trials, with FDA approval expected late this year or early next.
Now layer MOTS-C on top. The math gets interesting.
Retatrutide’s glucagon arm tells your liver to break down stored fat and dump fatty acids into the bloodstream. Without enough mitochondrial capacity to burn those fatty acids efficiently, they get recirculated and re-deposited, or worse, they overwhelm tissues that can’t handle the load (a process called lipotoxicity). MOTS-C addresses that exact bottleneck. It cranks up the cells’ ability to oxidize fat, so the fat Retatrutide mobilizes actually gets used as fuel.
That’s the cellular argument. There’s also a clinical one.
The most common complaint from patients on GLP-1 medications isn’t side effects. It’s energy. Appetite drops so fast that caloric intake plummets, and even though they’re losing weight, they feel wrecked. Workouts suffer. Afternoons get foggy. Some patients quit before they hit their goal because they can’t function.
Adding MOTS-C to a Retatrutide protocol has fixed that pattern in patients I’ve worked with at Formation. Not always, but often. By week three or four, energy stabilizes. Workouts come back. The fat loss continues at the same pace, but the patient isn’t running on fumes to get there.
I want to flag something here. Retatrutide isn’t FDA-approved yet. We’re discussing it because it’s the most promising compound in the pipeline and patients are asking about it constantly. But anything we do with Retatrutide at Formation runs under research protocols with full bloodwork tracking and medical supervision. Same goes for MOTS-C, which is currently in an ongoing Phase 2a clinical trial evaluating its effects on insulin sensitivity in adults with prediabetes and obesity.
Picture it like this. Retatrutide is the foreman who decides what gets pulled out of storage and tells the crew what to do. MOTS-C is the crew that actually does the work.
Actually, that analogy oversimplifies it. The better way to think about MOTS-C is as the infrastructure that makes the crew’s work possible. Without enough mitochondrial capacity, even a perfect signal from Retatrutide produces a backed-up system where mobilized fat doesn’t get oxidized. With MOTS-C running alongside, the infrastructure scales to match the demand.
Both peptides hit insulin sensitivity, but through different doors. Retatrutide improves it through GLP-1 and GIP signaling at the pancreas. MOTS-C improves it through AMPK activation in skeletal muscle, which is the largest insulin-responsive tissue in your body. Combined, you get a double improvement that’s especially useful for patients with prediabetes or early metabolic syndrome.
Both peptides also tamp down inflammation, but again through separate routes. Retatrutide does it indirectly, by stripping out the body fat that produces inflammatory cytokines. MOTS-C does it directly, by suppressing TNF-alpha, IL-6, and IL-1 beta at the cellular level. Patients running both compounds often see C-reactive protein drop within 8 to 10 weeks, which is faster than either peptide produces alone in my experience.
The muscle preservation piece is the one I care about most. Any aggressive fat-loss protocol carries a risk of dropping lean mass along with fat. A 2021 study in Nature Communications showed MOTS-C improves skeletal muscle metabolism and helps preserve muscle homeostasis, especially during caloric deficits. That’s the exact scenario Retatrutide creates. Adding MOTS-C gives the body a fighting chance to hold onto muscle while the fat comes off.
There’s also a longevity angle that doesn’t get talked about enough. MOTS-C is part of a small group of mitochondrial-derived peptides linked to longer lifespan in animal studies. The same anti-aging theme runs through related peptides too, with Tesamorelin and anti-aging research covering similar ground from a growth hormone angle. A specific variant of the MOTS-C gene also shows up in Japanese centenarians at higher rates than in the general population. That doesn’t prove anything in humans yet, but it’s a thread worth following.
What I won’t do: claim this stack delivers anti-aging benefits we can quantify. The data isn’t there yet. What I will say is that the metabolic profile patients end up with after 12 weeks (better fasting glucose, lower A1c, better lipids, more lean mass relative to fat) maps closely to what longevity researchers consider markers of healthy aging.
Yes, and a few combinations come up regularly in patient consultations at Formation.
The same logic that makes MOTS-C work with Retatrutide applies to semaglutide and tirzepatide, just to a lesser degree. Both of those are approved medications with longer track records. Patients already on a stable GLP-1 protocol who want metabolic support during their fat-loss phase tend to do well adding MOTS-C two or three times per week.
The tradeoff: results are less dramatic than the Retatrutide pairing because semaglutide and tirzepatide don’t hit the glucagon receptor. You don’t get the same liver-targeted fat mobilization. Still, the energy and muscle-preservation benefits hold up.
If you’re already on tirzepatide and curious about what to eat during your first week of any GLP-1 protocol, get that piece dialed in before you add anything else.
This is where I push back on a lot of the stacking advice you’ll see online. People combine MOTS-C with CJC-1295, Ipamorelin, Sermorelin, and Tesamorelin without thinking through what each one does.
The case for stacking MOTS-C with GH peptides is real. GH peptides handle body composition and recovery from the top down (signaling), while MOTS-C handles it from the bottom up (mitochondrial function). When the pairing works, patients see better muscle quality, deeper sleep, and faster recovery from training.
The case against: more compounds means more injections, more variables, and more chances for something to interact badly. If you’re choosing between adding MOTS-C to a GH peptide or adding a second GH peptide (compare hexarelin with ipamorelin if you’re in that decision), MOTS-C is usually the cleaner pick.
BPC-157 and TB-500 are repair peptides. Thymosin Alpha-1 is an immune-modulating peptide. Stacking MOTS-C with any of these makes sense when a patient is dealing with both a metabolic goal (fat loss, energy) and a tissue or immune issue (gut healing, joint recovery, post-illness rebuilding). The mechanisms don’t overlap, so there’s no receptor competition. Just understand that piling on more compounds means more cost and more complexity, and at some point the benefits stop scaling.
What I won’t recommend: stacking MOTS-C with Ibutamoren or other oral GH secretagogues purely for fat loss. The mechanisms get muddled, the GH side effects show up, and the metabolic gain from MOTS-C gets harder to isolate.
I’ll be specific because vague claims in this space drive me crazy.
For a patient stacking MOTS-C with Retatrutide over a 12-week period, here’s what I’ve seen at Formation in patients who follow the protocol and put the work in on nutrition and training:
What you shouldn’t expect: 50 pounds lost in 4 weeks. A complete personality reset. Becoming a different person at the cellular level overnight. Peptides amplify good habits. They don’t replace them. I tell every patient this and some still come back disappointed because their friend on TikTok promised faster results.
The other thing worth setting expectations on: outcomes vary. A patient in their 30s with no metabolic issues and a clean training history will respond differently than a patient in their 50s with insulin resistance and 80 extra pounds. Both can benefit. The trajectories look different.
This is the protocol I use most often at Formation for patients who are new to both compounds. It’s intentionally slow. Aggressive titration causes more dropouts than failure does.
Retatrutide at 1mg once weekly for the first two weeks, then 2mg once weekly for weeks three and four. Nothing else added during this phase. The goal is a clean baseline so we can see how the patient responds to Retatrutide alone.
The reason for this gap: if a patient adds two new compounds on day one and gets nauseous, headachy, or unusually fatigued, we have no way to know which one is responsible. Starting Retatrutide alone removes the guesswork. By the end of week four, we know whether the patient tolerates the GLP-1 piece and we have a stable dose to layer onto.
Bloodwork at week four. Always. Fasting glucose, A1c, complete lipid panel, liver enzymes, basic metabolic panel. Sometimes fasting insulin and a thyroid panel depending on the patient’s history.
Retatrutide titrated to 4mg weekly by week eight, with MOTS-C added at 5mg twice per week (Monday and Thursday mornings). This is the dose range most patients settle into.
For patients who tolerate well and want to push results, we sometimes increase Retatrutide to 8mg weekly between weeks 9 and 12, and bump MOTS-C to three times per week. That’s a more aggressive ceiling that not everyone needs.
For patients with rough GI side effects from Retatrutide, we hold at 4mg longer and let the body adjust. MOTS-C dosing stays the same regardless.
Bloodwork again at week eight and again at week twelve. The pattern matters more than any single reading.
A note on who does the actual injections at Formation. Jeff Atlas, our PA-C, handles peptide injections for our patients. Jeff came to us from an orthopaedic background, which means he has hundreds of hours of injection experience under his belt, and he brings the precision and patient communication that orthopaedic work demands. Patients sometimes assume Dr. Grandhige is going to inject them personally. He’s the surgeon. Jeff is the one with the needle.
Timing matters more for MOTS-C than for Retatrutide.
Retatrutide is once weekly with a long half-life. Pick a day and time, stick with it, and you’re fine. Morning is popular because any first-day nausea is easier to manage when you’re upright and moving. Some patients prefer evening so they can sleep through the early hours of side effects. Either works.
MOTS-C is different. Half-life is short, so when you inject affects what you get out of it. Morning injection on an empty stomach is my default recommendation. Patients who train fasted often inject 30 to 60 minutes before cardio or weights, which mimics the natural exercise-induced MOTS-C spike. Endogenous MOTS-C levels rise during exercise and return to baseline within about four hours, so the timing logic tracks.
Intermittent fasting protocols and MOTS-C have a real overlap. Both activate AMPK. Patients running a 16:8 fasting window who inject MOTS-C first thing in the morning often report the most consistent results, though I want to flag that I haven’t run a controlled comparison and this is mostly pattern recognition.
Can you inject both on the same day? Yes. Use different injection sites, use separate syringes, and put a few hours between them. We usually do Retatrutide in the evening and MOTS-C the next morning, which gives a clean separation.
Rotate injection sites. Abdomen at least two inches from the navel, outer thighs, and the back of the upper arms. The same site twice in a row is a quick way to develop irritation or lipohypertrophy.
Retatrutide carries the bigger side effect burden by a wide margin. The Phase 2 trial data showed nausea in roughly 28% of patients at the 12mg dose, diarrhea in 24%, vomiting in 17%, and constipation in 11%. These numbers peak between weeks four and eight, then taper as the body adjusts. About 11% of patients in the trial discontinued because of side effects.
MOTS-C is much milder. The most common reports are mild redness at the injection site, occasional small bumps that resolve on their own, and sometimes a few days of fatigue at the start as AMPK activation ramps up. No hormonal effects. No need for post-cycle therapy. No documented serious adverse events in the available research, though long-term human data is still limited.
When you run both compounds together, MOTS-C doesn’t appear to worsen Retatrutide’s GI effects. If anything, several of my patients have reported that adding MOTS-C made the early titration weeks feel more tolerable from an energy standpoint, even if nausea itself wasn’t reduced.
The side effect I watch for most carefully isn’t on either list. It’s the patient who feels great at week six and decides to push the dose higher than the protocol calls for without telling me. That’s where things go wrong. Retatrutide isn’t a compound where more equals better. Pushing past your tolerance window creates exactly the kind of GI mess that makes patients quit the protocol entirely.
For a detailed look at what side effects can look like with other compounds in this class, see the breakdown on cagrilintide peptide side effects. The patterns are similar across the GLP-1 family.
The FDA has placed MOTS-C in Category 2 of bulk drug substances for compounding, meaning there are noted safety risks that warrant restricted access. That category status doesn’t mean the peptide is dangerous in clinical practice. It means the FDA wants more data before allowing widespread compounding access. We watch the regulatory updates closely at Formation, including the Pharmacy Compounding Advisory Committee review scheduled for July 2026.
Not every patient is a candidate for peptide stacking, and being honest about this is part of why patients trust Formation in the first place.
Skip this stack if you’re pregnant, trying to conceive, or breastfeeding. The data isn’t there to support safety, and we won’t speculate.
Skip if you have active gastroparesis or any serious GI motility issue. Retatrutide will make it worse. I’ve turned down patients with this history more than once.
Skip if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. This is a boxed warning for the GLP-1 class and Retatrutide carries the same precaution.
Skip if you’ve had pancreatitis. Same reasoning.
Be very cautious if you’re on metformin. Metformin also activates AMPK, the same pathway MOTS-C hits. Stacking the two can amplify blood sugar lowering more than expected. Not necessarily dangerous, but it needs medical oversight and close glucose monitoring.
Be cautious if you’re under 25 unless there’s a specific clinical reason. Most patients in their early 20s don’t need exogenous peptides. Their natural production is fine. The MOTS-C drop happens later.
I want to be clear about one thing. This isn’t a stack you run on your own. I see Reddit threads of guys ordering peptides off sketchy websites, mixing their own protocols, and treating it like a supplement stack. That’s how people end up with contaminated injections, weird side effects they can’t explain, and bloodwork going sideways. If you’re going to run this stack, run it under medical supervision with proper sourcing and proper monitoring.
I want to walk through the patterns I see most often, because the mistakes are predictable.
Starting both compounds on day one. The single most common mistake. Patients want to feel results fast, so they layer everything at once. Then they hit a side effect and have no idea which compound caused it. We always start Retatrutide alone for two to four weeks before adding MOTS-C. Always.
Skipping bloodwork. Running a stack without baseline and mid-protocol labs is flying blind. We require both at Formation. No exceptions. The data tells us whether the protocol is working at the physiological level, not just whether the scale is moving.
Inconsistent MOTS-C dosing. Because the half-life is short, skipping doses leaves gaps in the metabolic signal you’re trying to build. If your protocol calls for three injections per week, get all three in. Sporadic dosing produces sporadic results.
Underestimating protein intake. Retatrutide hammers appetite, and the easiest macro to skip when nothing tastes good is protein. Patients lose muscle they wanted to keep because they were under-eating protein the whole time. Minimum 0.7 grams of protein per pound of bodyweight per day during any aggressive fat-loss protocol. I’d push closer to 1.0 for patients who train hard.
Buying peptides from random online vendors. The peptide market has a lot of unreliable suppliers. Purity matters enormously when you’re injecting these compounds. At Formation, we hold SSRP certification and ISSCA certification, both of which credential us specifically for working with peptides, exosomes, and stem cells. Those certifications mean something about sourcing standards and protocol oversight. Compare that to a patient ordering compounds from a website with no chain of custody and you can see why the outcomes diverge.
Treating peptides as a replacement for lifestyle work. This one frustrates me the most. I’ve had patients come in expecting MOTS-C to make them lean while they eat fast food five times a week. It doesn’t work that way. The peptides multiply effort. Zero effort multiplied by anything is still zero.
Reconstitution mistakes. Sounds basic, but people get this wrong. Never spray bacteriostatic water directly onto lyophilized powder. Aim it down the inside wall of the vial. Never shake the vial after reconstitution. Swirl gently. Small details, but they preserve peptide integrity and dose accuracy.
A few things separate the way we run peptides at Formation from what you’ll see at a typical wellness clinic.
First, we operate as a regenerative medicine clinic in Tampa with surgical credentials in the background. Dr. Grandhige is a board-certified general surgeon and spearheads the clinic’s peptide work from that medical foundation. We’re not running peptide protocols as a side service. They’re integrated with the regenerative medicine work we do day in and day out.
Second, Jeff Atlas, PA-C handles the actual injection appointments. Jeff came to Formation from orthopaedics, which means he’s done thousands of injections in technically demanding settings. That experience translates. Patients consistently tell us the injection appointments are calmer and more thorough at Formation than what they’ve experienced at GP clinics or wellness chains.
Third, we hold both SSRP certification and ISSCA certification. These organizations credential clinics specifically for working with peptides, exosomes, and stem cells. The certifications come with sourcing requirements, protocol standards, and ongoing review. Most clinics don’t hold either one. We hold both because regenerative medicine work demands that level of rigor.
Fourth, we don’t fast-track patients. Every peptide consultation at Formation includes a full medical history review, baseline bloodwork, goals conversation, and a frank discussion of whether peptides are the right tool for what the patient is trying to accomplish. Sometimes they aren’t. We’ve recommended patients work on diet and training for three months before coming back, and many of them do.
Tampa has plenty of clinics offering peptide injections. Most of them treat it like a transaction. We treat it like medicine, which means saying no when the patient isn’t ready, monitoring closely when they are, and adjusting protocols based on what bloodwork shows rather than what the patient wants to hear.
If you’re in Tampa and you want to talk through whether a MOTS-C stack makes sense for your situation, we’re happy to have that conversation. Bring your most recent bloodwork, a list of medications you’re on, and a clear sense of what you’re actually trying to accomplish.
Stacking MOTS-C with other peptides isn’t a shortcut. It’s a tool that works when the foundation underneath it is solid. Patients who get the best results from a MOTS-C and Retatrutide stack at Formation in Tampa are the ones who showed up already eating clean, training a few days a week, and tracking their own numbers. The peptides made their hard work pay off faster.
The ones who showed up looking for a substitute walked away unimpressed. That’s the honest pattern.
Yes, based on the available research. The two peptides hit different receptors and pathways, so there's no known direct interaction. Use separate injection sites, use separate syringes, and put several hours between them. Most patients at Formation handle this by injecting Retatrutide in the evening and MOTS-C the next morning. The gap helps identify any site-specific reactions.
Most patients report improved energy within 7 to 14 days of starting MOTS-C. Workout performance usually picks up by week three. Metabolic changes that show up in bloodwork (better fasting glucose, improved A1c, lower triglycerides) take 6 to 8 weeks to register. If you don't see anything by week 8, the dose is likely too low or the sourcing is suspect.
Yes. The pairings that hold up best involve peptides with different mechanisms. MOTS-C with growth hormone peptides like Sermorelin or Tesamorelin works well for body composition and recovery. MOTS-C with repair peptides like BPC-157 or TB-500 makes sense if you're dealing with both metabolic goals and a tissue or gut issue. Avoid stacking MOTS-C with multiple peptides that all hit similar receptors. That's where complications start.
No. MOTS-C works through AMPK signaling at the mitochondrial level. It does not interact with androgen receptors, estrogen receptors, or thyroid pathways. This is one of its biggest advantages as a stacking partner. You can add it to a protocol without introducing hormonal complications, which means no post-cycle therapy, no aromatase concerns, and no need to monitor sex hormone panels beyond what you'd already do routinely.
At Formation we run fasting glucose, A1c, complete lipid panel, liver enzymes (ALT, AST), complete blood count, and a basic metabolic panel as a baseline. Depending on the patient's history, we'll add fasting insulin, a thyroid panel, and inflammatory markers like hs-CRP. Repeat the same panel at week 8 and again at week 12 or whenever you finish the protocol. The trajectory matters more than any single reading.
It depends on the medication. Metformin and MOTS-C both activate AMPK, so combining them can push blood sugar down more than expected. Patients on insulin or sulfonylureas need close glucose monitoring on Retatrutide because hypoglycemia risk goes up. Patients on thyroid medication usually need no adjustment, but we check. Bring your full medication list to the consultation and we'll work through interactions one by one.
If you're a competitive athlete, no. MOTS-C is on the USADA and WADA prohibited substances list. For recreational training or general health optimization, it doesn't carry sport-specific implications, but if you compete in any sanctioned sport, this peptide is off the table for you.
Everyone’s anatomy and aesthetic goals are unique—which is why a personalized assessment is key.
Ready to see if Renuvion is the right fit for your transformation?
DM us or give us a call at (813) 922-2920 to schedule your consultation.
#renuvion #jplasma #skintightening #skingoals
Tampa, we have a secret… and ELLE Magazine just confirmed it. 😉✨
Say hello to Picofy by InMode—officially named the Best Glass Skin Laser by ELLE! And the best part? We are the ONLY clinic in Tampa that has it.
If you’ve been dreaming of that effortless, glowing glass skin with zero downtime, this is your sign.
Why we’re obsessed with Picofy:
🌟 Painless treatments (yes, really!)
🌟 Safe & effective for ALL skin tones
🌟 Ultimate skin rejuvenation, pigment reduction, and glow
Ready to upgrade your skincare routine?
Drop a 🪞 in the comments or head to the link in our bio to book your consultation!
You can also stop by for our open house this Thursday, July 30 to check it out in person!!✨🥂
“I just want to look like me, but fitter.” — Mission accomplished. 🙌
Here is an incredible 3-month update for our patient following a circumferential body lift with liposculpting.
By addressing excess skin 360 degrees around the beltline while strategically sculpting the chest, shoulders, and abdomen, we achieved a smooth, athletic frame without sacrificing a natural appearance. He looks leaner, stronger, and completely redefined.
Ready to start your journey? DM us or click the link in our bio to book your consultation.
#tampa #360lift #plasticsurgeryclinic
RSVP (link in bio) and get a raffle entry.
‼️get another raffle ticket for every three friends you tag. Unlimited entries. You can essentially guarantee a prize !
We’re going ALL OUT for our July 30th Party, and our raffle lineup this year is unmatched. 🥳
Every ticket you get puts you in the running for some serious glow-ups and top-tier treatments!
Take a look at what you could win:
1️⃣ 3-Pack Picofy Laser Facials✨($3,375 value)
2️⃣ COMPLETE Tattoo Removal — Unlimited sessions until it’s gone! 🚫🎨 ($4,340 value)
3️⃣ 100 Units of Botox 💉 ($1,500 value)
4️⃣ Full Syringe of Filler ( @juvederm ) 💋 ($900 value)
5️⃣ $500 Gift Card toward Peptides 🧬
6️⃣ FULL Permanent Makeup Brow Set (Nano/Powder/Combo)👁️✨ ($1,000 value) @bladingbybrent
7️⃣ Epicutis Gift Bag packed with luxury skincare 🛍️
*Exclusive Event-Only Discounts just for showing up!* 💸
Which prize are you claiming? Drop the number in the comments below! 👇💬
📅 When: July 30th
📍 Where: Formation (1315 S Howard Ave, Tampa)
⏰ Time: 5:30pm
Tag your party bestie who needs to enter with you! 👯♀️👇
Edited · 2d
1 Month Post-Op Transformation! 💥
Fixing previous surgical outcomes requires precision, expertise, and a tailored approach.
Here’s how Dr. Grandhige transformed this patient’s core and chest:
The Challenge:
Previous tummy tuck left uneven abdominal fat distribution
High scar placement creating a visible “shelf” effect
The Solution:
HD Liposculpture to refine and sculpt a athletic, masculine core and chest
Scar Revision to eliminate the shelf-like appearance and create a smoother profile
Keep in mind, at just 1 month post-op, swelling is still settling and we are nowhere near final results! Can’t wait to see this shape mature over the next few months. 🔥
💬 Questions about revision procedures? Drop them in the comments or send us a DM!
Trust the process. 🤍
This beautiful tummy tuck transformation is only 1 month post-op!
What makes this journey even more special is where it began. Two years ago, this patient came to us wanting change but wasn’t quite ready for the operating table. Instead of rushing, we partnered with her for the long haul. Through the strategic use of GLP-1 therapy, dedicated nutrition guidance, and mindset coaching, she completely transformed her health to get to where she is today.
While she is already looking incredible, it’s important to remember that residual swelling and inflammation are completely normal at this stage. Healing takes time, but the foundation for an amazing result is officially set!
We are so incredibly honored to be a part of every patient`s unique journey, and we are committed to being with you every single step of the way.
Drop a ❤️ to wish her a continued smooth recovery!
#TummyTuckJourney #PlasticSurgeryResults #BodyTransformation
Thinking about breaking up with your ink? 💔
Here is exactly why Formation should be your go-to for tattoo removal:
1️⃣ We use PICOFY: Our advanced picosecond laser treats all ink colors. No stubborn blues or greens left behind. 🎨
2️⃣ Fewer Sessions: Your time is valuable. Our laser targets ink more efficiently, meaning you get results in fewer visits than traditional lasers. ⏱️
3️⃣ Practically Painless: No, seriously. We can inject lidocaine under the skin to completely numb the area. Say goodbye to the “rubber band snap” feeling! 💉✨
4️⃣ Safe for ALL Skin Types: Our laser is highly precise and safe for every beautiful skin tone, minimizing the risk of hyperpigmentation. 🤎🖤🏼
Bonus reasons to choose Formation:
✨ Certified Laser Experts: We don’t do “one-size-fits-all.” Your treatment plan is completely customized to your skin, ink depth, and goals.
✨ Fading vs. Full Removal: Whether you want a clean slate or just want to fade a piece enough for a flawless cover-up, we’ve got you covered.
Stop living with a tattoo you’ve outgrown. Tap the link in our bio to book your free consultation today! 📲
#TattooRemoval #PicoLaser #PainlessTattooRemoval #InkRegret #FormationTattooRemoval
NOW is the time to start planning for next years summer body!
Schedule your consultation today to determine the next steps in your unique journey: https://formation.janeapp.com
#bodycontouring #Tampa #hdlipo
Face, neck, and chest—because your glow shouldn’t stop at your jawline. 😉👇
We are obsessed with the Picofy Laser for total skin rejuvenation.
Why we love Picofy:
✨ Full Coverage: Treats the delicate skin on your neck and chest just as effectively as your face.
✨ The Benefits: Boosts collagen production, shatters unwanted pigment, minimizes pores, and smooths skin texture.
✨ Minimal Downtime: Get that radiant glow without the lengthy recovery.
✨ Safe for ALL Skin Tones: Unlike older laser technologies, Picofy’s ultra-fast pulses deliver incredible results safely and effectively across the entire Fitzpatrick scale.
Ready to level up your skin game? 🤍 Click the link in our bio to book your consultation!
#Picofy #PicofyLaser #SkinRejuvenation #LaserSkinToning #AllSkinTypes
We previously posted this beautiful patient’s immediate before and after following her PDO Lifting Thread treatment.
Take a look at her fantastic results now that the 10 threads we placed are settled.
Send us a DM or click the link in our bio to schedule a consultation to discuss what treatments are the right fit for you!
#Tampa #Beauty #LiftingThreads #beforeandafter
References:
Reynolds, J. C., Lai, R. W., Woodhead, J. S. T., Joly, J. H., Mitchell, C. J., Cameron-Smith, D., Lu, R., Cohen, P., Graham, N. A., Benayoun, B. A., Merry, T. L., & Lee, C. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 12(1), 470. https://doi.org/10.1038/s41467-020-20790-0
Weng, F. B., Zhu, L. F., Zhou, J. J., & Shan, Y. Y. (2023). Mitochondria-derived peptide MOTS-c: Effects and mechanisms related to stress, metabolism and aging. Journal of Translational Medicine, 21(1), 36. https://doi.org/10.1186/s12967-023-03885-2
Li, H., Ren, K., Jiang, T., & Zhao, G. J. (2023). MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Frontiers in Endocrinology, 14, 1120533. https://doi.org/10.3389/fendo.2023.1120533
Lee, C., Zeng, J., Drew, B. G., Sallam, T., Martin-Montalvo, A., Wan, J., Kim, S. J., Mehta, H., Hevener, A. L., de Cabo, R., & Cohen, P. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 21(3), 443–454. https://doi.org/10.1016/j.cmet.2015.02.009
Merry, T. L., Chan, A., Woodhead, J. S. T., Reynolds, J. C., Kumagai, H., Kim, S. J., & Lee, C. (2020). Mitochondrial-derived peptides in energy metabolism. American Journal of Physiology-Endocrinology and Metabolism, 319(4), E659–E666. https://doi.org/10.1152/ajpendo.00249.2020
Peptides optimize the effort you are putting in. Get a FREE 15-minute Virtual Protocol Review + our Regenerative Treatment Newsletter.
We’ll show you exactly how we evaluate candidacy — plus, we cover the cost of your baseline labs with all in-person consults ($100).
